drugset / Trial / NCT01499498
The Boceprevir and Sildenafil Pharmacokinetics Study
NaSingle-groupOpen-labelTreatment
Summary
This is a healthy volunteer study looking at the interactions between two drugs: boceprevir and sildenafil. New drugs are being developed to treat people with the chronic viral infection hepatitis C. Very little is know how these new treatments interact with other medications such as the drugs used to treat erectile dysfunction. The purpose of this study is to look at levels of both a new hepatitis C drug called boceprevir (BOC) and an existing erectile dysfunction drug called sildenafil to see if they affect the blood levels of each other when given separately and together.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-04
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Boceprevir | Small molecule | 800 mg | — |
| Subject | Sildenafil | Unknown | 25 mg | — |